Franklin Street Advisors’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Franklin Street Advisors’s Portfolio ECYT Stock Details ECYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-22,425	Closed	-$398K	–	165
2018 Q3	$398K	Hold	22,425	–	–	0.05%	113
2018 Q2	$309K	Buy	+22,425	New	+$266K	0.05%	125

Other funds holding ECYT

OTC

Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return

Claro Advisors Boston, Massachusetts $830M AUM 21.8% 1-Year Est. Return

Franklin Street Advisors's ECYT Position: Q4 2018 in Review

Franklin Street Advisors sold out of Endocyte, Inc. Common Stock (ECYT) in Q4 2018, closing a stake of 22,425 shares — an estimated $398K sold.

Franklin Street Advisors first reported a position in ECYT in Q2 2018 and held it in 2 quarters. The position peaked at $398K in Q3 2018. 2 funds tracked by Wall St. Rank hold ECYT as of Q4 2018.

Franklin Street Advisors reported no remaining Endocyte, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
Franklin Street Advisors sold 22,425 Endocyte, Inc. Common Stock shares in Q4 2018, an estimated $398K.
Franklin Street Advisors first reported a position in Endocyte, Inc. Common Stock in Q2 2018 and held it in 2 quarters.
Franklin Street Advisors's Endocyte, Inc. Common Stock position peaked at $398K in Q3 2018.
2 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q4 2018.

Based on Franklin Street Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.